SCHEMBL62052

SCHEMBL62052

CCCCCCCCCC(O)(C[N+](C)(C)C)P(=O)(O)O

nearest known ligand 0.58

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 13/20 0.58
GGPS1 O95749 7/20 0.58
SMPD1 P17405 5/20 0.52
LPAR1 Q92633 1/20 0.52
LPAR3 Q9UBY5 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638947 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL60846 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL7188409 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL2695072 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL1044717 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL418810 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL2693656 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL632447 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL905578 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3
SCHEMBL60424 1.00 FDPS (0.58) FDPSGGPS1SMPD1LPAR1LPAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9513253-B2 Droplet actuators and techniques for droplet-based enzymatic assays ADVANCED LIQUID LOGIC, INC. (US) 2016-12-06 US claimed
US-20140246319-A1 DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS ADVANCED LIQUID LOGIC, INC. (US) 2014-09-04 US claimed
WO-2013009927-A2 DROPLET ACTUATORS AND TECHNIQUES FOR DROPLET-BASED ASSAYS ADVANCED LIQUID LOGIC, INC. (US) 2013-01-17 WO claimed
WO-2005007895-A1 METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES APPLERA CORPORATION (US) 2005-01-27 WO claimed
US-20050009036-A1 Methods and kits for obtaining nucleic acid from biological samples APPLERA CORPORATION (US) 2005-01-13 US claimed
US-12577543-B2 Method for producing polyisoprenoid by reaction catalyzed by mutant cis-prenyltransferase (CPT) family protein, and method for producing rubber product SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2026-03-17 US disclosed
US-20260002179-A1 METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSFORMED PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2026-01-01 US disclosed
US-20250326814-A1 MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF OPKO BIOLOGICS LTD. (IL) 2025-10-23 US disclosed
US-12391964-B2 Method for producing polyisoprenoid, vector, transformed plant, method for producing pneumatic tire, and method for producing rubber product SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2025-08-19 US disclosed
EP-1817048-B2 STABLE FORMULATIONS OF INSULINOPTROPIC PEPTIDES NOVO NORDISK AS (DK) 2025-06-18 EP disclosed
EP-3586142-B1 DETECTION OF MEMBRANE PROTEINS UNIV OXFORD INNOVATION LTD (GB) 2024-12-25 EP disclosed
US-12146146-B2 Method for producing trans-polyisoprenoid, vector, transgenic plant, method for producing pneumatic tire and method for producing rubber product SUMITOMO RUBBER INDUSTRIES, LTD. (JP) 2024-11-19 US disclosed
WO-2004104228-A1 MICROFLUIDIC PROTEIN CRYSTALLOGRAPHY CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2004-12-02 WO disclosed
WO-2004094020-A2 CRYSTAL GROWTH DEVICES AND SYSTEMS, AND METHODS FOR USING SAME FLUIDIGM CORPORATION (US) 2004-11-04 WO disclosed
EP-1392484-A4 HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS CALIFORNIA INST OF TECHN (US) 2004-07-28 EP disclosed
US-20040115731-A1 Microfluidic protein crystallography CALIFORNIA INSTITUTE OF TECHNOLOGY 2004-06-17 US disclosed
WO-2004038363-A2 MICROFLUIDIC DEVICE AND METHOD FOR PRESSURE-DRIVEN PLUG TRANSPORT AND REACTION THE UNIVERSITY OF CHICAGO (US) 2004-05-06 WO disclosed
EP-1392484-A2 HIGH THROUGHPUT SCREENING OF CRYSTALIZATION OF MATERIALS California Institute of Technology (US) 2004-03-03 EP disclosed
US-20030061687-A1 High throughput screening of crystallization materials CALIFORNIA INSTITUTE OF TECHNOLOGY, A CALIFORNIA CORPORATION 2003-04-03 US disclosed
WO-2002082047-A2 HIGH THROUGHPUT SCREENING OF CRYSTALLIZATION OF MATERIALS CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2002-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002179-A1 METHOD FOR PRODUCING POLYISOPRENOID, VECTOR, TRANSFORMED PLANT, METHOD FOR PRODUCING PNEUMATIC TIRE, AND METHOD FOR PRODUCING RUBBER PRODUCT FNTB, FNTA, TPT1 FDPS 11/4885GGPS1 4/4885SMPD1 3050/4885
US-20250326814-A1 MODIFIED OXYNTOMODULIN AND METHODS OF USE THEREOF OGFRL1, OXGR1, THOP1 FDPS 3765/4885GGPS1 3921/4885SMPD1 3534/4885
US-12577543-B2 Method for producing polyisoprenoid by reaction catalyzed by mutant cis-prenyltransferase (CPT) family protein, and method for producing rubber product FNTB, RTCB, PTAR1 FDPS 247/4885GGPS1 10/4885SMPD1 3516/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.